WallStreetZenWallStreetZen

NASDAQ: APLS
Apellis Pharmaceuticals Inc Stock Ownership - Who owns Apellis Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Apellis Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mark Jeffrey DelongChief Business Strat Officer2026-02-11368$22.15
$8.15kSell
Cedric FrancoisChief Executive Officer2026-02-038,840$3.76
$33.24kBuy
David O. WatsonGeneral Counsel2026-01-227,832$21.77
$170.46kSell
Cedric FrancoisChief Executive Officer2026-01-2227,192$21.77
$591.83kSell
Mark Jeffrey DelongChief Business Strat Officer2026-01-223,371$21.77
$73.37kSell
James George ChopasVPChief Accounting Officer2026-01-222,064$21.77
$44.92kSell
Nur NicholsonChief Technical Officer2026-01-227,725$21.77
$168.13kSell
Caroline BaumalChief Medical Officer2026-01-222,797$21.77
$60.88kSell
Pascal DeschateletsChief Scientific Officer2026-01-225,928$21.77
$129.02kSell
Timothy Eugene SullivanChief Financial Officer2026-01-2210,287$21.77
$223.90kSell

1 of 6

APLS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APLS insiders and whales buy or sell their stock.

APLS Shareholders

What type of owners hold Apellis Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Morningside Venture Investments Ltd10.00%12,806,342$525.32MInsider
Wellington Management Group LLP9.94%12,721,352$521.83MInstitution
Avoro Capital Advisors LLC9.55%12,222,222$501.36MInstitution
Vanguard Group Inc8.34%10,674,865$437.88MInstitution
Morgan Stanley7.17%9,173,004$376.28MInstitution
Deep Track Capital LP6.05%7,750,000$317.91MInstitution
Rtw Investments LP5.99%7,666,764$314.49MInstitution
Blackrock Inc4.89%6,260,113$256.79MInstitution
State Street Corp3.60%4,613,446$189.24MInstitution
Ubs Group Ag3.27%4,186,222$171.72MInstitution

1 of 3

APLS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APLS76.66%23.34%Net Selling
LEGN23.68%0.15%Net SellingNet Selling
XENE87.37%2.58%Net SellingNet Selling
CRSP68.96%31.04%Net BuyingNet Selling
LQDA49.58%50.42%Net SellingNet Selling
View Top Biotech Stocks

Apellis Pharmaceuticals Stock Ownership FAQ

Who owns Apellis Pharmaceuticals?

Apellis Pharmaceuticals (NASDAQ: APLS) is owned by 98.73% institutional shareholders, 30.05% Apellis Pharmaceuticals insiders, and 0.00% retail investors. Morningside Venture Investments Ltd is the largest individual Apellis Pharmaceuticals shareholder, owning 12.81M shares representing 10.00% of the company. Morningside Venture Investments Ltd's Apellis Pharmaceuticals shares are currently valued at $525.83M.

If you're new to stock investing, here's how to buy Apellis Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.